the secondary stage the reaction is one hundred per cent effective, and in the tertiary from seventy-five to one hundred per cent. In latent lues of an early period, that is, within four years, according to Halberstaedter, about fifty to seventy per cent will give a positive Wassermann reaction, while after that only thirty to fifty per cent. The positive \Vassermann rea,tion is. of course, diagnostic, since other condition,.<; in which it is found have an entirelv different clinical picture, especially in ear, nose and throat affections. Some of the conditions that give a positive Wassermann reaction are recurrent fever, leprosy, measles, scarlet fever, pneumonia, thrombosis, tnalaria, lead poisoning, tumors and cachexia. It is, however, difficult in the cases of a mildly positive or negative Vvassermann. Here all the clinical features of a lues ma.v be present, but the serologic test negative. This is ascribed to the mercury-fa!,t spirochetes or to the quicscent period of these organisms, and only aftcr a longer period of rcst from mercury. and after a repetition of the introduction of that drug or salvarsan, will the Wassermann rcaction become strongly positive. Gennerich and Heidingsfeld independently first showed this condition and called it the "provoking test."
Ag~in. a negative \Vassermann reaction and the absence of all dinic;tl phenomena of lues in a paticnt who has had the disease, but one who had been thoroughly treated, may be followed by recurrences, especially in the nervous system, within three years. After that he may be considered cured even in the presence of a \Vassermann reaction, according to Fritz Lesser. Citron, and others, while Halberstaedter and others will hear nothing of a time limit as to when a patient is cured. Noguchi recently introduced a new reaction for syphilis, which . is analogous to the cutaneous reaction for tuberculosis, and is known as the luctin rcaction. This is especially adapted to the latent stages of syphilis, because in many instances the \Vassermann reaction is negative, while the luetin is positive. Again. it is absolutely negath'e in a healthy as well as cured syphilitic. So that, according to Noguchi, when the allergy (skin reaction) does not occur and the patient has also a negative \Vassermann after having becn treated, he may he considered cured, regardless of time.
A \Vassermann reaction may remain' positive in spit,:: of antiluetic treatment for a very long time, and this is explained on the basis that neither mercury nor ,salvarsan has reached all the spirochetes. The latter are located in structures that are penetrated with difficulty by these remedies; as, for instance, the cerebrospinal system, nerves and cornea. Especially is this true when small doses are given, whereas one large dose of salvarsan transforms the positive Wassermann reaction into a negative one. It has been demonstrated that the later the antiluetic treatment is begun in a case, the longer in proportion will it require to change a positive to a negative \Vassermann.
In the examinations of the cerebrospinal fluid it has been shown in quite a number of instances by the Appelt-~onne test that this fluid has been infected with lues, while the Wassermann reaction of the blood was negative, and correspondingly in cases of faintly positive Wassermann reaction this test of the cerebrospinal fluid may be strongly positive.
SALVARSA~.
The subject of the application of salvarsan in general has been so thoroughly exploited and references in the literature are so numerous that I shall nofgo into this part with any great detail, but shaH confine my remarks principally to otolaryngologic matter, with special reference to the complications or recurrences, and .especially those of the auditory nerve.
Jn the January number of Chemotherapy, the references and reports which have been compiled from the principal naions of the world, show that from July, 1911 , to October, 1911 , four hundred and ninety-five articles have appeared, among which America leads with 156, France 138. Russia 73, Germany (and this is noteworthy) 66, England 31, and Italy 31.
Since that time the reports have materially increased. So far as the literature on salvarsan in otolaryngology is concerned, reports of complications in the auditory nerves preceded those of the great benefits from this remedy. Chiari and Gerber were the first to report cases, and the interesting points they brought out were that threatening laryngeal obstruction, where one would be in fear of the action of potassium iodid, on account of a possible edema, cleared up with remarkable rapidity, when salvarsan was administered. Felix, of Bucharest, made one of the e~r1iest and most~n couraging reports of salvarsan in 'otolaryngology from his large experience. Aft~that quit~a number of isolated reports in discussions of papers on subjects other than syphilis or salvarsan appeared in this country and abroad. Dr. Thomas J.
Harris, in such a discussion, was one of the earliest to report in Kew York on the great value of this remedy, but a definite and complete reference has not as yet appeared, although I know papers have been presented at the meetings just held of the New York State Medical Society and American Laryngological Society.
According to Leonore Mic~aelis, it is derived from atoxyl, which contained five values of arsenic, whereas salvarsan only contains three values. On account of its phenol acid property, as well as the property of its amin, it is considered a base. It combines, therefore, with sodium hydrate, a sodium salt, and with hydrochloric acid, a salt of carbohydrates. It is soluble in water, and if exposed to air in dry form becomes oxidized and brown in color. This change adds very materially to its poison-' ous effect, and it is, therefore, necessary not to employ any preparation for~olution except from hermetically sealed bottles or tubes. There is 34 per cent of arsenic in salvarsan.
Schereschewsky, Hoffmann and Noguchi made it possible to experiment with this drug in pure culture of spirochetes transferred into rabbits, and it was found by Hata that their destruction followed almost immediately the injection of salvarsan. Ascoli, Pasini, Siedknid and Truffi showed that ma.rked degenerative changes in the spirochetes followed the injection of salvarsan, and they could not be found after two to three days. Not only superficial lesions showed the disap-pearance of the spirochete so rapidly, but Jaffe and Henck excised chancres and, after staining by Levaditti method, demonstrated their destruction in one to three days. In con-· genital lues Herxheimer showed that three days after the injection the spirochetes were absent from the whole body, except the lungs, where they were found in a markedly degenerated condition. Similar findings are reported by Reinke in another postmortem examination, only here it was four days following the injection. It is noteworthy that Ehrlich and Plaut have shown that salvarsan has no effect on the spirochetes outside of the body.
METHOD OF APPLICATION.
Three methods of application are known, the Weichselbaum or subcutaneous method being the first of which use was made; second, the intramuscular, and, third, the intravenous. The subcutaneous method has been practically abolished, on account of its painfulness and tendency to abscess formation. As to the choice and indications of the intramuscular and intravenous, it is still an undecided question; in fact, both methods have their advantages and disadvantages, as well as distinct indications and contraindications. I shall not go into the detail of the controversies, but will state the methods that I have or rather am employing at the present time. .
Intramusc;ular Method.-Schindler and Neisser recommend the preparation known as Joha, which is a mixture of salvarsan in iodipin, in ampules, already prepared, and in doses of 0.4 to 0.6 of salvarsan in 1.0 to 1.5 of iodipin oil. One may prepare his own mixture by properly and thoroughly triturating the aRents in their proportions and under the strictest aseptic conditions. Enough may be made for stock for a number of injections.
The technic is the same as for any other deep muscular injection. Recently I have incorporated, at the suggestion of Ormsby, a small quantity of soft paraffin, which reduces the irritation _to the minimum.
Intravenous Method.-There are awo conditions that are of importance in this pr~edure: 1. Experience in the intro-. duction of the needle and the general management of technic.
2. Absolute sterilization of everything that is employed, especially the water that is used as the menstruum. Distilled water is best.
It is not necessary to lay the vein bare, as~otthaft has declared; this not only prolongs the procedure, but adds to the possibilities qf complications as well. It is necessary to do this only in the rarest instances and in very stout pcrsons with small veins.
Steps of the Procedure.-(a) Preparation of the solution. About 40 cc. of warm, freshly prepared normal salt solution is poured into a .graduate breaker (with a glass stopper and about twenty glass beads) measuring about 300 cc. 1'0 this is added the entire quantity of the ampule of salvarsan (0.6), and this is shaken until all the yellow crystalline substance is dissolved. Add further about 200 cc. of the salt solution and shake again. Then, with a dropper, add about 20 minims of a 15 per cent sterile and filtered sodium hydrate solution, which produces a cloudy solution. The sodium hydrate solution is added drop by drop until the whole mixture becomes clear. The remainder of the 300 cc. of the salt solution is now added and the whole solution well mixed; if the least cloudiness is present, some more of the sodium hydrate is to be added. A litmus paper test will show it to be either neutral or slightly alkaline.
All three different solutions have been used-acid, alkaline, and neutral, but it is the latter that is most frequently employed. Duhot claimed a quicker and more permanent action from acid solution, but this has not been substantiated by others.
(b) Apparatus.-Therc arc more than forty types, many very similar, that I have been able to find suggested, but the main principlc!' are those of any transfusion syringe. The container should have a capacity of about 300 cc., held on an iron stand that may be varied in height so as to regulate the pressure. There should be a firmly secured rubber tubing not too long and wide, at the end of which is attached the canula needle. which has a three point stopcock. To one of the other nipples of this stopcock is attached another tube, going to a second container, which also rests on the stand and "is for the purpose of flmhing the vein with normal salt solution before and after the injection of salvarsan. The third opening of the stopcock is to determine that one is in the vei'n by the escape of a little blood, which is eventually taken at this time for a Wassermann test.
(c) Injection.-Both the containers are to be filled, one with salvarsan, and the other with salt solution.' Patient is put in the recumbent position. A rubber tube is applied around the uppermost part of the arm, but not too firmly, because slight paresis of the musculospiral nerve has been observed and considered a complication of salvarsan administration. One of the prominent veins is to be selected, preferably on the forearm, because it is less inconvenient afterwards than within the elbow. The region of this vein is tapped slightly, making it more prominent (Weichselbaum) . The needle is passed through the skin into the vein in a very oblique, almost flat, manner for about a half inch. The stopcock is opened so that the return of the blood may be observed. The vein is relieved by removing the Esmarch rubber tubing from the arm and about 10 cc. salt solution allowed to enter. This is followed with the salvarsan. It should take about half an hour for the entire quantity (250 to 300 cc.) to enter the drculation. At the end of this time a flow from the salt solution of about 10 ce. is permitted, the ryeedle is removed and a light pressure bandage applied. Patient is returned to bed, not walking, and told to remain quiet for about a day. Dosage.-At the beginning Ehrlich, when he spoke of thẽ terilizatio magna advised that one large dose be given, bl1t this has not been found as satisfactory as the sterilizatio fractionata, and smaller doses only, but often repeated, are now the rule. Kromayer recommended what he called a chronic salvarsan treatment-an injection of 0.2 three times weekly until a dose of 2.0 to 3.0 was reached within four to six weeks. This method did not find great favor. The most satisfactory dosage appears to be in active cases 0.5 every third day, so that after twelve to sixteen days the treatment is completed. In the more latent cases one injection of 0.5, followed several weeks later by another, with an interval of mercurial treatment, is the rule. However, in arteriosclerotic individuals, or those afflicted with heart, kidney or nervous diseases, a very small dose, say 0.1, is given, to find out how it reacts, and then it is gradually increased. In infants the smallest dose and the smallest amounts are advised, say 5 cc., containing 0.01, and this is to be repeated four or five times. Jesioneks found that these smaIl doses often provoked the symptoms and appeared to make conditions worse, so that Ehrlich and Weichselbaum recommended the maximum dose of 0.1 at one time. Welde showed that even larger doses 'were well tolerated, and Baisch gave in a newborn, and with good results, 0.15 twice within ten days. Children from two to ten years of age tolerate doses as high as 0.1 to 0.3.
The Excretion of the Salvarsan.-According to Fischer and Hoppe, Frankel and Grouven, Ullmann and several others, who have studied this question, there seems to be a great variance of opinion, and this is due to the difficulty of obtaining and weighing the arsenic from the excretions. Lockmann says that salvarsan, of all the other arsenic preparations, is the slowest to be completely excreted. In the first twenty-four hours after injection 0.2 to 20 per cent is excreted. After seven and a hal f weeks 0.003 per· cent was found in the daily urine in cases of intravenous injections, and 0.03 per cent in subcutaneous injections, ten weeks later, and 0.01 per cent thirteen and a half weeks later could still be found. Formerly it was thought that in subcutaneous and intramuscular injections the excretion of the salvarsan was much slower than in the intravenous method, but Bornstein and Lockmann have shown that this is not true, and that the liver, spleen, kidney, bone marrow and muscles serve as a storehouse for the arsenic in this as well as in all the methods.
According to Frankel, Navassart and others, the intestinal tract as well as the kidneys are the principal structures of excretion of the arsenic, mostly from the intestines. Abelin could find arsenic as early as five to ten minutes after an intravenous injection, and in the intramuscular after half an hour. Resorcin is employed as a test for the arsenic. However, one finrls that the salvarsan has not been split up or changed very much by its passage through the blood, unless, as Bornstein believes. the arsenic forms again with the urine and feces a compound much like the original salvarsan. Loeb has shown that long after the urine shows no trace of salvarsan, it may still be found in goodly quantities in the blood, and would assign this fad to the possibility of a chronic arsenic intoxication. These findings were not accepted. No one has as yet determined the lethal dose of salvarsan, but there is no question that such must exist, in spite of the fact that even after very large doses thus far given there have been no disastrous results.
(l) l\lalignant or grave lues.
(2) Lues in which there exists an idiosyncrasy against mercury.
(3) Lues that is very refractory to mercury.
(4) In cases where, for prophylactic reasons, a rapid sterilization is necessary.
(5) Recurrences or socalled complications in the nervous system.
(6) In luetic patients who are also infected with tuberculosis, and who, as a rule, tolerate mercury very poorly.
(7) In cases of lues where, in spite of a very vigorous and long continued mercury treatment, the Wassermann reaction remains positive.
. (8) As a diagnostic measure it is far superior in time to mercury. CONTRAI NDICATIONS.
(1) In ocular diseases in which there has been employed some of the other arsenical preparations, as hektin, eneso!, arsacetin, or atoxyl, one must not employ salvarsan. In no ocular disease, especially when of luetic origin, is there any contraindication for its use.
(2) In heart diseases and aortic aneurism great care should be exercised, and only the smallest doses should be admini!'tered, if at all. In c~ses of heart failure complicated by nephritis, tabes, general paresis, it is, according to Ehrlich, contraindicated.
(3) Kidneys: Acute nephritis, except the luetic type, is an absolute contraindication to the use of salvarsan.
(4) Gastrointestinal: Ulcerative conditions of stomach and duodenum, owing to the possibility of rupture.
(5) Liver: Acute swelling or chronic cirrhotic or atrophic livers prove very dangerous conditions, since here is the main depot for the salvarsan.
(6) General nervous system: In all cases of marked proressive degenerative changes, especially where arteriosclerosis is present. In cases where a typical Herxheimer reaction take.s place, and where the danger zone of the centers~comes affected by this reaction.
(7) Diabetes and general marked obesity, in consequence of eueral alcoholism, are very dangerous conditions in which to employ salvarsan, on account of the fatty heart.
COMPLICATIONS.
Complications following the use of salvarsan are not many at the present time, since the technic is very l1mch better under· stood, and tho~e conditions which formerly were looked I1pon as complications are in the main known as luetic recurrences, and react most beautifully to more salvarsan, mercury and potassium iodid. Especially are these recurrences or reignited syphilis manifest in the general nervous system, and principally in the peripheral nerves. The kidneys, liver, and other parenchymatous structnres are next in frequency in what the Germans call "provokatorische recediven." There are, however, certain symptoms rather than complications that follow the use of salvarsan, but these are, as a rule, so transitory and leave no changes behind, that I will only enumerate some of them, and go more into detail in discussing the affection of the auditory nerve:
A group of symptoms, such as sudden redness and swelling of the face, marked difficulty in respiration, and an irritative short cough, great pressure and hot feeling in the head, the expression of great anxiety, paresthesias of the extremitie~, have been observed by a number following immediately theinjection of salvarsan, especially intravenously. Recently, Iwaschenzow has published his experience with this particular subject and believes that we are dealin~with a sort of anaphylactic condition; that the principal cause is the too early repetition'an(l of too small doses of salvarsan, a phenomenon similar to injection of other sera. All these manifestations disappear from one-half to five minutes later. There is no change in the pulse. Epileptiform seizures, convulsions, syncope, and complete loss of consciousness have been reported. A marked rise of temperature, diarrhea, nausea and vomiting occur, but less frequently.
Some of the manifestations of the skin that were observed following the injection of. salvarsan were an eruption resembling scarlet fever and measles, urticaria, herpes zoster, herpes faeialis and labialis, dermatitis exfoliata, put, most interesting of all, the Herxheimer reaction. The reaction is a swelling of the.ti~sues usually brought about by the introduction of some chemical substance (potassium iodid or salvars:m) into a brJcty that has been previously fairly well saturated with mercury. According to this explanation, accepted by Ehrlich and many others, the many recurrences of lues, especially in the nervous system, which will be described later, arc due to this' Herxheimer reaction.
As to the kidneys, hemorrhagic nephritis or simple hematuria, tran!'itory albuminuria and slight nephritis, with granular casts, arc recorded.
Marked jaundice is reported from probable affections of the liver or its gall ducts. . As otologists, we are particularly interested in three point!': First, in cases of luetic affection of the acoustic nerve, is salvarsan indicated or not? Second, in luetic patients with a history of a preexisting labyrinthine nonluetic affection, are we justified in advising against the injection of salvarsan? and. lastly" and most important, is the question of the affection of the auditory nerve, either the acoustic, vestibular or both, the result of salvarsan injections? rn answer to the first and second questions the great rna· jority of authorities agree that salvarsan should be employed, and same of the most brilliant .results are reported from salvarsan in acute luetic labyrinthitis.
As to the question of auditory nerve affection following salvarsan, I will say that the authenticated literature and iny personal investigations and observations, as I will show later, do not bear out those alarms that started in Finger's c1in.ic in Vienna, and have been continually reported and rereported. In consequence thereof in many cas~s in which salvarsan waĩ ndicated it was withheld, and thus a better result prevented. \Ve are thankful for these early observations of the Vienna school, and hope that !'ubscquent observations of these cases will show that the majority of the cases proved to be only temporary, most probably due to changes which I now will describe. There are two type!' of changes in the nerve possible after salvarsan injections: the acute, taking place one to two days after, and the other the latent, occurring several day!' or weeks after injection. Ehrlich says that the nerves are the most difficult of all the tissues to be reached by salvarsan~On the other hand, the nerves are very frequently infected hy the spirochete.
Ullmann, in animal experiments with destructive doses of salvarsan, could find arsenic everywhere except the nervous system, and supports Ehrlich's contention.
The acute. affections of the auditory nerve following salvarsan injection are~poken of as neuroreactions by Troumer, and are explained as foIlows: The' spit:ochetes, through a long period of mercurial treatment, become nonactive and mercury-fa5t, so that additional mercury will have no effect on them, and when the salvarsan is injected, it brings them back into action. Since the salvarsan cannot reach the spirochetes very weIt within the nerves, as has been shown above, through their action at these points certain endotoxins are liberated and there results' an acute swelling of the nerve, and thus the sudden affections.
A mercurial and potassium iodid treatment, with a possible second dose of salvarsan, will clear up, as it has already done in many instances, most of these acute cases.
As t~the latent nerve affection that foIlows two to eight months after the injection, there cannot, according to Weichselmann, Ehrlich, Benario, Guttmann, and others, be any question that these are true luetic recurrences, due to an incomplete sterilization of the whole system by one or two injections and in many instances to the inadequacy of the dose employed. In opposition to this opinion are Finger, Rille and others, who ascribe this condition as being due to the toxic action of salvarsan. Benario, in order definitely to determine the pathogenesis I)f this late manifestation of the nerves following the injedion of salvarsan, collected 220 cases of nerve affection from the literature, and for comparison 123 cases of the same affections following the use of mercury, for the same cry was once raised against mercury as now is against salvarsan. The results of his tabulated studies are as follows: .
That these nerve affections (the auditory included) are syphilitic recurrences is proven by the following:
1. They occur exclusively during the early period of the secondary stage of the disease, at.a time when the dispersion of the spirocheta' is at its height.
2. They were not .se~n in cases other than syphilitic treated with salvarsan (exception of Heidingsfeld's case).
3. They are influenced and 'Curable by repetition of salvarsan injections.
4. The pathologico-anatomic process, as seen in the eye Eundus, is an acute inflammation, while the arsenic produce.. atrophic. noninflammatory changes.
That these nerve affections are not due to the toxicity of salvarsan is sbown further bv: .
01.
The long interval betwe~n injection and the first symptoms. 2. They have not occurred if salvarsan was administered correctly.
3. They have occurred where the dose of salvarsan injecte:l was small. 4. They do not occur in cases that already show symptoms of nerve affection. 5. The same changes have occurred when mercury was employed im;tead of salvar!'an.
The same author has found that ofoall the luetic recurrences in the nerves, the auditory predominates to the percentage of 44.5 per cent.
In the lntern.ationales Cent,.alblatt fur Ohrenheilkunde, Valentine recently reviewed this whole subject of the auditory nerve affections following salvarsan, and comes to this conclusion: "It certainly shows that from the en<~rmous numbEr of cases that have been injected, but a very small number have been damaged in the region of the auditory nerve, and surely one may reconcile this difficulty with the. most remarkable successes with this remedy-salvarsan." He has classified the cases into two groups: (1) Acoustic affection alone. (2) Acoustic affection with other nerves, and the acoustic nerve affection into (a) cochlearis; (b) vestibularis; (c) cochlearis and vestibularis.
There are 43 cases in all that he could find in the literature. Of these there were 9 of cochlear, 7 vestibular, 20 combiner! of both portions. and in 9 other cranial nerves were involved also.
Benario, in the Muenchener medicinische Wochenschrift, gives his collected cases from literature, and personal inquiry, numbering 14,000 cases treated, and 126 secondary nerve affections, (If which 62 were of the acoustic nerve. These were divided into 29 cochlear, 5 vestibular, 17 both cochlear and vestibular, and 1I in combination with other' cranial nerves.
Frey, Duel, and more recently "Grbantschitsch, .have ex,. pressed themselves of the belief that no permanent injury of the auditory nerve occurs following the use of salvarsan.
An interesting case of nonluetic origin is reported by Milian, in which two salvarsan injections were given, causing trouble with the auditory nerve. Since the case, however, had been previously given hektin (arsenic) for some time, it cannot be accepted as a case of arsenic injury from salvarsan. Another case of lichen planus, reported by Wanner, in which salvarsan caused some trouble with the auditory nerve, would be accepted as a case of toxic effect from salvarsan on the auditory nerve, but the report is very incomplete and cannot be accepted as such at this time. One case of O. Beck must be mentioned, in which, foHowing salvarsan, bilateral deafness ensued. Mercury was given, without result. Then pilocarpin was given, with good result. He believes pilocarpin enhanced the excretion of the salvarsan from the system.
An interesting contribution to~he subject since Valentine's review is by Knick and Zaloziec, in the Berliner. klinische W ocltenschrift: "Acute Acousticus Involvement in the Early Period of Syphilis, with Special Reference to Salvarsan." They describe in tabulated and complete form ten cases, in which they found that most of the cases where large doses of salvarsan could be given cleared up quickly; however, those of combine(~brain. syphilis with labyrinth involvement were slow in recovering, owing to the small doses that were given by necessity. The spinal punctures showed cellular elements and in a number showed a positive test for syphilis (AppeIt-Nonne), whereas in the same case a negative Wassermann existed.
In making an extensive investigation of the effect of salvarsan in treatment of syphilis in general, I have communicated either by letter or in perSall with forty-two physicians, most of them specialists in genitourinary and skin and veneral diseases, outside of Chicago, and herewith state my results. I wrote to physicians in the following cities: Philadelphia, • Pittsburg, Xew York, Buffalo, Baltimore, Cincinnati. St. Louis. Boston, WashingtOJ1, Detroit, :\Jontreal, Toronto, St. Paul, Minneapolis, Toledo, Kansas City, Denver, San Francisco, Los Angeles, New Orleans, Louisville. Duluth, Jacksonville, Birmingham, Nashville, Vicksburg, Knoxville, Cleveland, Columbus, Albany, Harrisburg, Salt Lake City, Asheville, Indianapolis, Omaha, Dallas, San Antonio, El Paso.
As to complications, most of the men report very few, espe-cially in reference to the auditory nerve. A goodly number were still very sanguine about ,the use of salvarsan, although thus far, when they employed it, the results were very satisfactory. The publishing of all the correspondence would probably be of interest and profit, but spa,ce will not permit it. I will, however, present the two extreme reports, and if Heidin~8feId is correct in his interpretation of his cas<', then it is the second case that I have been able to find in the literature of permanent injury to the auditory nerve.
"Dear Doctor Beck:
"May 3, 1912. "In reply to your letter of April 30th, I beg to state that I have just read a paper before the Xew York State Medical Society, at Albany, on the effects of salvarsan on the eye and ear. 'fhis will later be published in the Journal of the State Association.
"I have given the drug now about one thousand times intravenously and have seen no case where it has produced any injurious effect on the ear or eye. It is extremely important. however, that details of technic be carefully observed, the most important of which is the preparation of the drug with freshl~r distilled water.
Sincerely yours,
"),Iv Dear Dr. Beck: "'In reply to your kind letter of Aprj) 30th, I beg to refer you to my most recent contribution on the subject of salvarsan, namely, an article which has just appeared in the :May 4, 1912, issue of the N (,7£1 York Medical]ollrnal.
"In answer to your query, I beg to state that up to the present time I have observeci five cases of impaired hearing with intravenous administration of salvarsan. There was impaired hearing in two of the cases prior to the administration of salvarsan, and in two cases the impairment manifested itself subseqnent to the administration. Two of these cases have pro-ceec1eu to satisfactory recovery after an interval of three to fonr months. The other two cases have 110t as yet shown any material improvement. The fifth case is one of unusual interest, inasmnch as it demonstrates that the impairment of hearing must have been dne to the intravenons administration of salvarsan and to no other attributable cause. This patient had a well-defined case of scabies and presented no history or clinical evidence of existing or preexisting syphilis. The patient fell into the hands of an unqualified, incompetent physician, who admintstered salvarsan intravenously. Within two weeks after the administration the patient came to my personal notice with impaired hearing. A Wassermann examination at that time was absolutely negative in character and remained negative for a period of four weeks. The patient presented no clinical evidence of existing or preexisting syphilis. To my mind, the impaired hearing in this case must be justly attributed to the intravenous administration of salvarsan, in so far as syphilis was not associated, and it manifested itself within a few days after the intravenous administration of the remedy.
"Very sincerely, " (Signed) M. L. HEIDINGSFELD, "Cincinnati."
On inquiry of the Chicago profession at large, and especially the genitourinary and skin and venereal specialists, I was able to obtain the following information: From 182 men, who had used this remedy for syphilis, in very many injections and cases, there had never been a death, nor any difficulty with the auditory nerve, with the-exception of slight irritation, as dizziness or ringing in the ear, always passing away within a short time. Some reported late· manifestation-; of the anditory nerve whi-eh responded to more mercury and salvarsan, in that they cleared up.
DEATHS REPORTED IN LITERATURE.
Ehrlich and his followers claim that in not a single instance has there been a case demonstrated but what would show that the patient had, previous to the injection, changes of such nature as could explain the cause of death, independent of the~alvarsan.
1. Gaucher (France). Two deaths; symptoms 0 f meningitis; no postmortem.
2. 'rucker (America). Man, thirty years. One hour after injectian of 0.3 salvarsan, intravenously, symptoms of chills, vomiting, high temperature.~o postmortem.
3. Goldenberg and Kolaski (America) . Alcoholic. Two weeks after injection, intravenously, of salvarsan had symptoms of mania. 4. Pederson (America). Man, thirty. Brain gummi and hemiplegia, and growth in rectum. 0.45 salvarsan, intramuscularly. Twelve days later died from intracranial hemorrhage. Albumin in urine.
5. Wolbarst (America). Man, thirty-eight. Tabes. Died twelve days after injection. No arsenic could be found the first three days after injection; after that, semicoma. Before he was injected he had a mild nephritis, with albumin and granular casts.
G. Fordyce (America). Woman, twenty-five. Dead on second day after the second injection of 0.4, intravenously. A trace of albumin showed, and some red blood cells, after the first injection. A few days later, when the above second dose was given, the temperature rosc very high. Vomited. This continued until the following day. Next day anuria and drop in blood pressure to 60. Autopsy showed acnte nephritis and hemorrhal;e in the liver.
7. Longe (Italy). Boy, four years old. Symptoms of acute ari'cnical poisoning thirty-six hours after injection, 10travenously, of 0.08 of salvarsan. No postmortem.
The cases that I have treated by means of salvarsan are as follows: 
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In all of these cases the Wassermann test showed in most instanccs strongly positive. All but one case had either previously or subsequent to the injection of salvarsan, mercury and potassium iodid treatment, one case for eight years. Twenty-eight of these patients are now cured, so far as the repeated Wassermann being negative shows, and clinically all of the forty-seven cases are well. The majority were treated by the intravenous method. The majority had more than one injection, and one case, a pharyngeal lues with pathologic conditions in the eyes, fingernails and tibia of an active type, had five salvarsan (0.6) infusions within seven months, with marked benefit, but at the present time has still a marked positive Wassermann reaction. Most of the patients gained greatly in weight and improved in their general health. In three cases there was a typical Herxheimer reaction following the injections. One case, a. colored woman, had all the symptoms described as anaphyla1ctic following salvarsan, and she is the one case that had no other antiluetic treatment before or after the injection of salvarsan, and repeated Wassermann reactions since proved to be negative. This patient gained thirty pounds after the treatment within a month. Her Wassermann reaction was strongly positive before the salvarsan injection.
In not a single instance was there any trouble with thc ears following the injections, except a ringing, which disappeareo within a oay or two.
In ·conclusion, I desire to state that the new preparation soon expected will be haileo with hopes that some of the objections .to salvarsan will be met, and this great remedial agent will become the universally applied specific for the cure of lues.
I also wish to state that I freely useo the publication of Richarcl Sieskind in the January number of the Berliner . Klinik.
Since this article was read the author has treated about twice as many cases of this kind as are reported and has observed no untoward effects on the acoustic nerve from the use of salvarsan. Furthermore, no reports of ill effects from the use of salvarsan have come to the author's notice, either by personal communication or through correspondence from any of the many men who employ this method of treatment.
Referring to the case' of Dr. IIeidingsfe1d, reported in this article. the author herewith gives a copy of a letter receiveo from Dr. Heidingsfeld shortly after the reading of this article, relative to the case: "I beg to inform you that the case of impaired hearing in a patient who had scabies and a negative Wassermann, has lately developed some active manifestations of syphilis, in which .spirochete pal1iela have been demonstrated. The impaired hearing, therefore, in this case, cannot be attributed solely to the influence of salvarsan, as I first surmised."
The author wishes to make the following statement with regard to his employment of neosalvarsan, the latest substitute for salvarsan itself. It has been employed in a number of cases, particularly intramuscularly, in repeated small doses, with absolutely no bad effects, either on the nerve, nor other untoward effects attributable to the use of salvarsan. One particular advantage is its rapid solubility, but the pain caused by the injection seems to be equally as great as when using salvarsan.
